COMMISSIONER OF CENTRAL EXCISE, CALCUTTA versus M/S. SHARMA CHEMICAL WORKS

COMMISSIONER OF CENTRAL EXCISE, CALCUTTA versus M/S. SHARMA CHEMICAL WORKS

Neither the proportion of medicament present in the product, nor the mode of selling, nor prescription status determines classification; Banphool Oil contains ingredients as prescribed in Ayurvedic texts, is manufactured under a drug license, and the Board Circular process was followed resulting in the Drug Controller classifying it as 'Ayurvedic Medicament'. Revenue did not prove that the product is popularly known as hair oil; thus, Tribunal's classification as 'Ayurvedic Medicament' is correct.

Parties
Appellant: Commissioner of Central Excise, Calcutta; Respondent: M/s. Sharma Chemical Works
Jurisdiction
India
Judgment Date
30 April 2003
Procedural Posture
Civil Appeal / Supreme Court Judgment on Appeal From Central Excise, Customs and Gold (control) Appellate Tribunal
Outcome
Appeals dismissed
Legal Topics
Tariff Classification, Excise Duty, Interpretation of Medicaments Under Central Excise Tariff
Tax Law Central Excise Tariff Classification Excise Duty Interpretation of Medicaments Under Central Excise Tariff

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Legal principles 5 Authorities cited 9 Party arguments 2
Sign in to unlock

Parties

Commissioner of Central Excise, Calcutta

Appellant

M/s. Sharma Chemical Works

Respondent

Procedural Posture

Civil Appeal / Supreme Court Judgment on Appeal From Central Excise, Customs and Gold (control) Appellate Tribunal

Legal Issues

  1. 1 Whether 'Banphool Oil' is classifiable as an 'Ayurvedic Medicament' under Tariff Item 3003.30 or as 'perfumed hair oil' under Tariff Item 3305.10 of the Central Excise Tariff Act, 1985.

Ratio Decidendi

Neither the proportion of medicament present in the product, nor the mode of selling, nor prescription status determines classification; Banphool Oil contains ingredients as prescribed in Ayurvedic texts, is manufactured under a drug license, and the Board Circular process was followed resulting in the Drug Controller classifying it as 'Ayurvedic Medicament'. Revenue did not prove that the product is popularly known as hair oil; thus, Tribunal's classification as 'Ayurvedic Medicament' is correct.

Court Disposition

Appeals dismissed

Orders

  • Banphool Oil is classifiable as an Ayurvedic medicament under Tariff Item 3003.30.
  • Impugned judgments of Tribunal affirmed.